Literature DB >> 3535398

A follow-up study of 68 patients with anti-mitochondrial antibodies (AMA).

R Jorde, O P Rekvig, L Bostad.   

Abstract

During the period 1976-83, anti-mitochondrial antibodies (AMA) were detected in 68 patients out of about 48 000 sera (0.14%) analyzed for a repertoire of autoantibodies at the Department of Immunology, University Hospital of Tromsø. Fifty-five of these patients were women, and only 10 had unequivocal primary biliary cirrhosis (PBC). At follow-up in 1984, 48 out of these 68 patients were accessible for complementary testing. The AMA test became negative in 17 of these 48 patients during the observation period. Eleven of these 17 had originally a titer of 50. Seven of the 31 patients with persistent AMA were without detectable liver pathology. One patient had antibodies against smooth muscle, one against cell nucleus, whereas 35 had an increased serum IgM level. In conclusion, most patients with AMA do not have obvious PBC, a low AMA titer is likely to be transient, and there is a strong association between AMA and an increased serum IgM level.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3535398     DOI: 10.1111/j.0954-6820.1986.tb02758.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


  4 in total

1.  Antimitochondrial autoantibodies in anti-glomerular basement membrane disease.

Authors:  J B Marriott; D B Oliveira
Journal:  Clin Exp Immunol       Date:  1993-08       Impact factor: 4.330

2.  Low rate of new-onset primary biliary cholangitis in a cohort of anti-mitochondrial antibody-positive subjects over six years of follow-up.

Authors:  T K Felder; E Aigner; S Zandanell; M Strasser; A Feldman; J Tevini; G Strebinger; D Niederseer; G Pohla-Gubo; U Huber-Schönauer; S Ruhaltinger; B Paulweber; C Datz
Journal:  J Intern Med       Date:  2019-12-04       Impact factor: 8.989

Review 3.  Primary biliary cirrhosis.

Authors:  Simon Hohenester; Ronald P J Oude-Elferink; Ulrich Beuers
Journal:  Semin Immunopathol       Date:  2009-07-15       Impact factor: 9.623

4.  Crohn's disease of the small bowel, complicated by primary biliary cirrhosis, Hashimoto thyroiditis, and Raynaud's phenomenon: favorable response of all disorders to adalimumab treatment.

Authors:  John K Triantafillidis; Spyros Durakis; Emmanuel Merikas
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2013
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.